Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Treatment of postpartum depression, part 1: a critical review of biological interventions

Despite the recent upsurge of interest in this area, many questions remain unanswered, resulting in diverse research implications.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors critically reviewed the literature on biological treatments for postpartum depression, examining nine studies that met their criteria. Interventions included antidepressants, estrogen therapy, critically timed sleep deprivation, and bright light therapy. The authors report that methodological limitations make the efficacy of these treatments equivocal, with limited strong evidence to guide practice.

Studies included
9
Who or what was studied
Women with postpartum depression
Limits stated in the abstract
The authors note methodological limitations in the included studies and a lack of randomized controlled trials, leaving the evidence for efficacy equivocal.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatrist.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Depression, Bright light therapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies

Mental Health

[Pharmacotherapy of seasonal depression]

So far, selective serotonin reuptake inhibitors and possibly compounds with a distinct noradrenergic mechanism of action seem to be the treatment of choice for seasonal depression.

Review · January 1, 2002 · Hilger E et al.